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Eur J Vasc Endovasc Surg (2011) 42, 127e128CORRESPONDENCEComments regarding “Predictors of Stroke and
Paraplegia in Thoracic Aortic Endovascular
Intervention”Dear Editor,
I would like to thank the authors of the recent article
“Predictors of Stroke and Paraplegia in Thoracic Aortic
Endovascular Intervention” for their contribution to the
literature.1 One major current issue in the management of
thoracic aortic pathologies relates to the management of
the left subclavian artery (LSCA). More historical data
suggested that the revascularisation of the LSCA was
unnecessary prior to endografting the thoracic aorta or
aortic arch. However, more recently, a considerable body
of evidence, based around large single centre series, have
suggested that revascularisation of the LSCA is mandated in
cases where coverage is required to achieve a suitable
proximal aortic landing zone.2 This has been shown to
reduce death, stroke and paraplegia rates.
It was surprising therefore that, given the extremely
strong evidence in favour of LSCA revascularisation, only 9%
of patients in the reported series actually had the LSCA
revascularised. This comprised eighty-seven patients from
their series that had the LSCA covered (29.7% of all cases),
but revascularisation in just 9.2% (8/87). Even for those
patients with a zone 1 landing zone only 21.9% (7/32) had
LSCA revascularisation. A failure to demonstrate an effect
on paraplegia requires further dissection of the case-mix as
this runs against previous evidence.
Morepositively, the authors reached the sameconclusion,
that LSCA revascularisation is associated with the better
surgical outcomes compared to covering the LSCA without
revascularisation. It is hoped that this message reaches
other surgeons performing these high-risk procedures.References
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Response to comments regarding “Predictors of
Stroke and Paraplegia in Thoracic Aortic Endovascular
Intervention”Dear Editor,
We thank the authors for their interest in our paper.1 The
issue of revascularising the left subclavian artery (LSCA)
when the origin is deliberately covered during thoracic
endovascular aortic repair (TEVAR) remains controversial.
In common with their own experience we changed our
indications for revascularising the LSCA during the course of
our experience, having a lower threshold for performing
this later in the series. We agree that this is beneficial for
reducing stroke.
The claim that the evidence for revascularisation of the
LSCA is “extremely strong” is not borne out by the litera-
ture. The recommendation by the Society for Vascular
Surgery to revascularise the left subclavian during TEVAR
when the origin is deliberately covered by the device is
categorised as C as it is based on level III evidence. There
are no randomised controlled trials on this subject and to
perform one may be considered unethical. The assertion
that revascularisation of the left subclavian is now
“mandated” would suggest that it is obligatory.
Carotid subclavian bypass is not without risk. Compli-
cations include damage to the brachial plexus, the phrenicDOI of original article: 10.1016/j.ejvs.2011.03.020.
128 Correspondencenerve and the thoracic duct. In some patients access can
make the operation difficult and loss of the proximal
subclavian into the thorax can be fatal. Revascularisation of
the LSCA when the left vertebral artery is of small calibre or
absent or if the right verterbral artery is dominant is of
limited value.
The authors’ own series failed to show that carotid
subclavian bypass prevented stroke or paraplegia when
assessed independently.2 It did prevent death, but most of
the deaths occurred in the emergency group which had
a low rate of revascularisation (4/28; 14%) compared to
the elective patients (31/50; 62%). To take a composite
end point of stroke, paraplegia and death may allow
statistical significance, but the independent effect of
LSCA revascularisation on the incidence of stroke remains
unproven.
We believe that each patient requires careful assess-
ment to evaluate neurological risk, and there is a danger
that dogma will undermine individualised patient care.
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